Ann: Significant Growth in Commercial Treatment Sales in Q4 FY24, page-27

Digga it's hard to answer that question because the company has said it won;t release quarterly number of implants sold because, as the numbers are still low, that would essentially give away their pricing information, and they still have variable pricing. This will change once reimbursements are more established.

Right now we know the $ sales per quarter and the total number of implants (200 reported last month).

Most implants right now are being funded by the company as part of 2 major studies. When they stop, if they are positive, more private sales are likely to occur. And hopefully the trials will lead to government reimbursement, rather than hospital based , philanthropic, private health insurance based, or privately funded reimbursement.